Actively Recruiting
Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma
Led by First Affiliated Hospital, Sun Yat-Sen University · Updated on 2023-05-16
474
Participants Needed
1
Research Sites
365 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial is a multi-center phase III clinical trial. The purpose of this trial is to explore whether 2 cycles induction chemotherapy combined with concurrent chemoradiotherapy is not inferior to 3 cycles induction chemotherapy combined with concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.
CONDITIONS
Official Title
Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 65 years old
- Pathologically confirmed non-keratinizing nasopharyngeal carcinoma
- Stage T3-4N0-1 according to UICC/AJCC 8th edition
- No distant metastasis
- No prior anti-cancer treatment
- ECOG performance status of 0 or 1
- Adequate blood, liver, and kidney function
You will not qualify if you...
- Treatment intended for palliative care
- Diagnosed with other malignant tumors at the same time
- History of malignant tumors
- Pregnant, breastfeeding, or planning pregnancy during the trial
- Presence of serious combined illness
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Other (Non U.s.), China, 510080
Actively Recruiting
Research Team
C
Cheng-Tao Wang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here